TrialBMC pediatrics2016

The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.

Carmel T Collins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.